Format

Send to

Choose Destination
Curr Treat Options Cardiovasc Med. 2017 Jul;19(7):49. doi: 10.1007/s11936-017-0553-3.

The Role of Cardiac Biomarkers in Pregnancy.

Author information

1
Division of Cardiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
2
Division of Cardiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. Asarma1@partners.org.

Abstract

Cardiovascular disease (CVD) is the leading cause of pregnancy-associated mortality, with an increasingly complex pregnant population. While our understanding of CVD in pregnancy continues to evolve, there remains a need to develop widely accessible tools to follow pregnant women both with and without preexisting disease with respect to cardiovascular risk, particularly for those presenting with symptoms suggestive of cardiovascular pathology. Thus, research is emerging with respect to the potential role of novel and established cardiac biomarkers in diagnosing and following CVD in pregnancy. Here, we review the normal hemodynamics of pregnancy and the behavior of various biomarkers in both normal and complicated pregnancies.

KEYWORDS:

Cardiac biomarkers; Peripartum cardiomyopathy; Preeclampsia; Pregnancy

PMID:
28516275
DOI:
10.1007/s11936-017-0553-3

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center